Foodstuffs used during LPVD were chosen according to their PRAL value so that the diet would enhance the alkali production as much as possible. However, the general dietary guidelines were taken STI571 in vitro into account as well. The subjects were given exact instructions how to realize LPVD. All the days during the vegetarian diet were similar and the diet mainly contained vegetables and fruits. The use of grain and dairy products was very limited. The subjects were not allowed to eat e.g. meat, cheese, eggs or bread at all during the 4 days. During both LPVD and ND the subjects were instructed to eat according to their energy needs and they reported the amount

of foods eaten in a food diary. Blood sampling and analysis For the analysis of acid–base balance, Li-heparinized whole blood samples (200 μl) from a fingertip capillary selleck chemicals were analyzed immediately after sampling for pH, lactate, HCO3 – and pCO2. For the Thiazovivin clinical trial determination of pH the direct ISE (ion selective electrolyte) in vitro test was used. Lactate was analyzed quantitatively by the enzymatic and amperometric in vitro test. PCO2 was analyzed by the membrane amperometric method. HCO3 – was determined

computationally (Nova Biomedical STAT Profile pHOX Plus L Blood Gas Analyzator, Nova Biomedical, Waltham, MA, USA). Whole blood samples (4 ml) from the antecubital vein were collected to Venosafe gel tubes and analyzed for sodium, potassium and chloride by the direct ISE in vitro test (Ion Selective Microlyte Analyzer, Kone Instruments, Espoo Finland). Whole protein content of plasma and serum albumin were analyzed spectrophotometrically by the Biuret method (Shimadzu CL 720 Micro-Flow Spectrophotometry, Shimadzu Co., Kyoto, Japan). Glucose was determined from the Li-heparinized fingertip samples (200 μl) quantitatively by the enzymatic

and amperometric in vitro test (Nova Biomedical STAT Profile pHOX Plus L Blood Gas Analyzer). Non-esterified free fatty acids (FFA) and triglycerides (TG) were analyzed from the antecubital whole blood sample (4 ml). The blood samples were drawn in vacuum tubes and were centrifuged for 10 min at 3500 rpm. The serum was separated and FFA and TG were then analyzed by the spectrophotometric and enzymatic method. For oxyclozanide the determination of FFA, NEFA C-kit was used (Shimadzu CL 720 Micro-Flow Spectrophotometry). During cycling, the gaseous exchange was measured using Sensor Medics Breath Gas Analyzator (Vmax series 229, California, USA). The device was calibrated before every measurement. VO2, VCO2, RQ and VE were determined as a mean from the final 30 seconds of every stage. Heart rate was measured by a Polar heart rate monitor (Polar Electro Oy, Kempele, Finland). SID and Atot were calculated as follows: SID (mEq/l) = ([Na+ + [K+) - ([Cl- + [Lac-) [3], Atot (mEq/l) = 2.43 × [Ptot (g/dl) [17].